Oregon News Headlines

Creative Biolabs Released Cancer IVD Antibody Development Services

 Breaking News
  • No posts were found
November 20
21:55 2018
New York, October 20th, 2018 — Creative Biolabs released cancer in vitro diagnostic (IVD) antibody development services focused on cancer biomaker detection for the treatment of multiple cancers including breast cancer, lung cancer, bladder cancer, etc.

New York, October 20th, 2018 — Creative Biolabs released cancer in vitro diagnostic (IVD) antibody development services focused on cancer biomaker detection for the treatment of multiple cancers including breast cancer, lung cancer, bladder cancer, etc.

Cancer is a genetic disease caused by out-of-control cell growth. Unlike regular cells, cancer cells do not experience programmatic death but continuously grow and divide to form a mass called a tumor. Most cancers are initially recognized either because of the appearance of signs or symptoms or through screening.

For the sake of better treatment effects on various cancer, in vitro diagnostic (IVD) antibodies, critical components of different antibody-based kits or diagnostic assays, are developed to bring hopeful results to cancer patients. Based on advanced technology platform, customized IVD antibodies in Creative Biolabs can be provided with high affinity and specificity to the target biomarker.

“Our seasoned experts can not only develop tailored IVD antibodies against a wide range of cancer markers but also have extensive experience in ancillary techniques and services such as antibody purification and characterization. Both hybridoma and phage display technologies are available for custom antibody development,” a scientist from Creative Biolabs said.

“The biomarker discovery and assay service can provide monoclonal and polyclonal antibodies generated in different host species, and recombinant antibodies of both full length (species and isotype switching) and partial length (scFv, Fab, F(ab)2, BsAb). Our antibody products are consistent, high-affinity, and reliable products for both research and industry.”

There are over 200 different types of cancer, and each is classified by the type of cell that is initially affected. Below are the following most recently viewed cancer types covered in CBL’s development of diagnostic antibodies:

Follicular Adenoma

Melanoma

Leukemia

Testicular Cancer

Breast Cancer

Pancreatic Cancer

Bladder Cancer

Brain Cancer

Gastrointestinal Cancer

Prostate Cancer

Cholangiocarcinoma

Germ cell cancer

Liver Cancer

Neuroendocrine Tumor

Renal Cancer

Colorectal Cancer

Glioblastoma

Lung Cancer

Myeloma

Esophageal Cancer

Glioma

Lymph Cancer

Ovarian Cancer

Thyroid Cancer

Others

As a leading company in the IVD industry, Creative Biolabs works side-by-side with our clients to develop the crucial antibodies that will drive your assay development forward. Contact us and experience the great value of our expert services if you are interested in in vitro diagnostic (IVD).

 

About Creative Biolabs

Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients’ requirements.

 

Media Contact
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/drug-discovery/diagnostics/

Recent Posts

Electrosurgery Accessories Market is anticipated to reach US$ 2209 million, witnessing a CAGR of 5.9% during the forecast period 2024-2030 | The Market Reports

Read Full Article